Menu
1 min read · estimated
APPROVED USE
What FDA approved
For adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.
LAMPGEN ANALYSIS
Why it matters
The action added a BTK inhibitor option for CLL and SLL across treatment settings.
What research teams should watch
Document treatment history and assess comorbidities and concomitant medications when evaluating fit.
PRIMARY RECORDS